Trials / Completed
CompletedNCT03361280
Removal of Beta Blocker Drugs by Hemodialysis
Beta-blocker Dialyzability in Maintenance Hemodialysis Patients
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Eight maintenance hemodialysis patients are given one of four beta blocker drugs (atenolol, bisoprolol, carvedilol, metoprolol) three hours prior to a hemodialysis session. Blood samples and spent dialysate are collected during dialysis. On separate dialysis sessions, patients received the other study drugs until they have taken each of the four study drugs. Dialytic clearance is calculated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Beta blocker | Beta blockers are administered as described in arms. |
Timeline
- Start date
- 2015-02-27
- Primary completion
- 2016-03-10
- Completion
- 2016-03-10
- First posted
- 2017-12-04
- Last updated
- 2017-12-04
Source: ClinicalTrials.gov record NCT03361280. Inclusion in this directory is not an endorsement.